Literature DB >> 9022600

Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.

Y Abramov1, V Barak, B Nisman, J G Schenker.   

Abstract

OBJECTIVE: To assess the potential involvement of vascular endothelial growth factor in the hyperpermeability characterizing the ovarian hyperstimulation syndrome (OHSS).
DESIGN: A controlled clinical study that followed the kinetics of vascular endothelial growth factor in the plasma of patients with severe OHSS from the time of admission to the hospital and until clinical resolution.
SETTING: Women hospitalized with severe OHSS in a tertiary medical center. PATIENT(S): Seven patients with severe OHSS after ovulation induction for IVF and seven controls who had received a similar ovulation induction regimen and did not develop the OHSS. INTERVENTION(S): Three blood samples were obtained from each OHSS patient: upon hospitalization for severe OHSS, when significant clinical improvement was evident, and on the first follow-up visit after the patients' discharge. Ascitic fluid was obtained from all OHSS patients by therapeutic paracentesis during the active phase of the syndrome. Blood samples were drawn from the control patients 4 to 6 days after ET. All samples were assayed for vascular endothelial growth factor levels, hematocrit, E2 levels, and white blood cell count. MAIN OUTCOME MEASURE(S): Vascular endothelial growth factor levels were assayed by ELISA. Estradiol was determined by RIA. RESULT(S): Compared with the controls, high levels of vascular endothelial growth factor were detected in the plasma of all patients admitted for severe OHSS. Levels dropped significantly along with clinical improvement, reaching minimum values after complete resolution. A statistically significant correlation was found between plasma vascular endothelial growth factor levels and certain biologic characteristics of OHSS and of capillary leakage such as leukocytosis and increased hematocrit. Ascitic fluid obtained from the study patients also contained high vascular endothelial growth factor levels. CONCLUSION(S): These findings suggest the involvement of vascular endothelial growth factor in the pathogenesis of capillary leakage in the OHSS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022600     DOI: 10.1016/S0015-0282(97)81908-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

Review 1.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

2.  Ovarian granulosa cell tumor presenting as Meigs' syndrome with elevated CA125.

Authors:  Kwon Choi; Hyun Jong Lee; Ji Cheul Pae; Suk Joong Oh; Seong Yong Lim; Eun Yoon Cho; Seung Sei Lee
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

3.  Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle.

Authors:  Osamu Tokuyama; Yoshihiro Nakamura; Ayako Muso; Yuji Fujino; Osamu Ishiko; Sachio Ogita
Journal:  J Assist Reprod Genet       Date:  2002-01       Impact factor: 3.412

Review 4.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

5.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

Review 6.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

7.  Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.

Authors:  E R Levin; G F Rosen; D L Cassidenti; B Yee; D Meldrum; A Wisot; A Pedram
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

8.  An update on the prevention of ovarian hyperstimulation syndrome.

Authors:  Omar El Tokhy; Julia Kopeika; Tarek El-Toukhy
Journal:  Womens Health (Lond)       Date:  2016-08-19

9.  Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.

Authors:  Amanda K Hurliman; Leon Speroff; Richard L Stouffer; Phillip E Patton; Annette Lee; Theodore A Molskness
Journal:  Fertil Steril       Date:  2009-05-23       Impact factor: 7.329

Review 10.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.